Skip to main content

TODAY ONLY – up to $1,800 OFF weight loss plans Ends in: 10h 0m 0s left!

Weight Loss

Tirzepatide.

This page provides general educational information about tirzepatide — a dual-agonist medication that may be discussed in medically supervised weight management. It is not medical advice and does not determine eligibility for treatment.

Overview

Tirzepatide is a dual-agonist medication that acts on GLP-1 and GIP receptors.

Dual-agonist medications represent a category of prescription treatments that may be considered in certain clinical contexts, including weight management when evaluated by a licensed healthcare professional. They involve signaling pathways related to appetite and metabolic regulation — but suitability and response vary by individual.

Townley Health provides this information to support informed conversations about care. Whether tirzepatide or any related treatment is appropriate depends on clinical evaluation — not on educational content alone.

How this type of medication is used in clinical care

Use in practice is determined by a prescribing clinician.

In clinical settings, dual-agonist medications may be prescribed for eligible patients as part of a medically supervised weight management plan. A clinician considers diagnosis, health history, concurrent medications, and applicable clinical guidelines before making recommendations.

Treatment plans may include monitoring, lifestyle guidance, and follow-up. Medications in this class are not appropriate for all individuals, and a clinician may recommend alternatives or decline to prescribe.

Clinical evaluation

Eligibility is assessed individually — not through a website checklist.

Before tirzepatide or a related medication is considered, a licensed healthcare professional typically reviews factors such as current weight and related health conditions, medical history, prior treatments, allergies, pregnancy or breastfeeding status, and other medications or supplements in use.

Certain conditions, medications, or history may make this class of treatment unsuitable or require additional caution. Completing any online information-sharing process does not guarantee that treatment will be prescribed.

Important safety considerations

Dual-agonist medications can have significant side effects and contraindications. People with certain medical histories — including some thyroid conditions, pancreatitis history, or severe gastrointestinal disease — may not be candidates.

Common side effects can include nausea, vomiting, diarrhea, and other gastrointestinal symptoms. Serious adverse events are possible and should be reported to a clinician promptly.

Review Townley Health’s Safety Information and Medication Information resources, and discuss your personal risk profile with a licensed healthcare professional.

Questions to discuss with a healthcare professional

Useful topics for a clinical conversation.

  • Is a dual-agonist medication potentially appropriate for my health history and current medications?

  • How does this category differ from other GLP-1-based options that may be considered?

  • What side effects should I watch for, and when should I seek urgent care?

  • How will my response and ongoing suitability be monitored over time?

  • How does medication fit alongside nutrition, activity, and other lifestyle factors?

Compounded medication context

Compounded products are not the same as FDA-approved manufactured medications.

Frequently asked questions

Tirzepatide

Medication information

General guidance on prescription medications and responsible use.

View medication information

Safety information

Emergency direction, responsible participation, and when to seek in-person care.

View safety information

Continue learning

Explore the broader weight management overview or see how the Townley Health experience works.